Carcinoma: all 6,719 studies
Page 62 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular CarcinomaCompletedNCT00825474Not applicable
- A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck CancerCompletedNCT00824343Phase 2
- Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)TerminatedNCT00823290Phase 1
- Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of LungTerminatedNCT00822016
- Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular CarcinomaCompletedNCT00820157Not applicable
- Paclitaxel and Cisplatin for Thymic NeoplasmTerminatedNCT00818090Phase 2
- Intraoperative Chemotherapy Against Hepatocellular Carcinoma RecurrenceCompletedNCT00817895Not applicable
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)Status unknownNCT00817583Phase 2
- Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal CarcinomaStatus unknownNCT00817258Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal CarcinomaStatus unknownNCT00816855Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal CarcinomaStatus unknownNCT00816816Phase 2
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell CancerTerminatedNCT00816686Phase 1
- Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT00816634Phase 2
- Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood VesselsCompletedNCT00814242Phase 2/3
- Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00814086Phase 1
- Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With SorafenibCompletedNCT00812175
- Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00807300Phase 2
- Songyou Granule and Transarterial Chemoembolization for Hepatocellular CarcinomaStatus unknownNCT00805896Phase 2
- Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00805012Phase 2
- Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)CompletedNCT00804128
- Imiquimod 5% Cream for the Treatment of Periocular Basal Cell CarcinomaStatus unknownNCT00803907Phase 4
- Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT00802555Phase 1
- Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and NeckTerminatedNCT00797043
- INSIGHT - Post Marketing SurveillanceCompletedNCT00792350
- Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTerminatedNCT00791544Phase 1/2
- Vorinostat in Treating Women With Ductal Carcinoma in Situ of the BreastCompletedNCT00788112Phase 1
- A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell CarcinomaCompletedNCT00788060Phase 1
- Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsStatus unknownNCT00786110Phase 2
- IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)CompletedNCT00785122Phase 1/2
- Phase I/II Study of TSU-68 for Advanced Hepatocellular CarcinomaCompletedNCT00784290Phase 1/2
- Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT00778908Phase 2/3
- Efficacy of Adjuvant Mitotane Treatment (ADIUVO)Status unknownNCT00777244Phase 3
- Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00771641Phase 3
- A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®CompletedNCT00771147
- Laryngeal Preservation in Pyriform Sinus CarcinomaCompletedNCT00770393Phase 2/3
- Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular CarcinomaCompletedNCT00769535Not applicable
- Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerCompletedNCT00769405Phase 3
- Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver CancerCompletedNCT00769106Phase 3
- Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular CarcinomaStatus unknownNCT00768157Phase 4
- Permission to Collect Blood Over Time for ResearchTerminatedNCT00767234
- Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT00766480Not applicable
- Tumor Growth Factors in Hepatocellular CarcinomaCompletedNCT00764140
- Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.Status unknownNCT00759382
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid TumorsCompletedNCT00756847Phase 1
- A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT00756782Phase 2
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck CarcinomaCompletedNCT00753038Phase 2
- A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00752570Phase 2
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation TherapyStatus unknownNCT00751543Not applicable
- Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)CompletedNCT00749320Not applicable
- SBRT + TACE for Primary Hepatocellular CarcinomaWithdrawnNCT00746655Not applicable
- microRNA Expression in Renal Cell CarcinomaCompletedNCT00743054
- Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast CancerCompletedNCT00742222Phase 4
- A Phase II Study of AS1411 in Renal Cell CarcinomaStatus unknownNCT00740441Phase 2
- FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal CarcinomaWithdrawnNCT00735241Phase 2/3
- A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal CarcinomaCompletedNCT00733889Phase 2
- Sequential Study to Treat Renal Cell CarcinomaCompletedNCT00732914Phase 3
- Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00728078Phase 2/3
- Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.Status unknownNCT00727350Phase 2
- Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal CarcinomaWithdrawnNCT00725400Phase 2
- Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian CarcinomaCompletedNCT00721890Phase 2
- The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular CarcinomaStatus unknownNCT00720668
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00719303Phase 3
- Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy SpecimensCompletedNCT00718367
- T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)CompletedNCT00717743
- Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized StudyStatus unknownNCT00715286Phase 3
- A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of ChemotherapyCompletedNCT00714025Phase 2
- A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT00712855Phase 1
- Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)CompletedNCT00712790Phase 1/2
- Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or CombinationWithdrawnNCT00712621Phase 2
- Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)Status unknownNCT00707681Phase 2
- A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT00705627Phase 3
- Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00703365Phase 2
- Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)Status unknownNCT00699829
- Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00697905Phase 2
- Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of BladderCompletedNCT00694915Phase 2
- Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of BladderCompletedNCT00694798Phase 1
- 11C-Acetate PET/CT Non-FDG-Avid TumorsStatus unknownNCT00687778
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT00683631
- Single Agent Abraxane as Second Line Therapy in Bladder CancerCompletedNCT00683059Phase 2
- Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma TreatmentCompletedNCT00678119Phase 2
- Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT00677118Phase 3
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line ChemotherapyCompletedNCT00676507Phase 3
- Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity CancerTerminatedNCT00670397Phase 1
- Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)Status unknownNCT00669747Phase 2
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular CarcinomaTerminatedNCT00669136Phase 1
- Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological ControlStatus unknownNCT00663650Phase 3
- Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous NefrectomyCompletedNCT00663559Phase 2
- Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine CarcinomaCompletedNCT00663429Phase 2
- Sexual Behavior in Head and Neck Cancer PatientsStatus unknownNCT00662662
- Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular CarcinomaCompletedNCT00662246Phase 1
- An Investigation of Small Intestinal Carcinoid Carcinoma in FamiliesStatus unknownNCT00662168
- BAY43-9006 Phase II Study for Renal Cell CarcinomaCompletedNCT00661375Phase 2
- Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction ChemotherapyTerminatedNCT00661011Phase 2
- Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of ProgressionWithdrawnNCT00659399Phase 1
- Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
- CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTerminatedNCT00653952Phase 3
- Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)Status unknownNCT00652613Phase 2
- Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular CarcinomaCompletedNCT00652587Phase 3
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1